Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05364736

Effect of Prebiotics on Blood Pressure Management

An Interventional Study for the Effects of Highland Barley β-glucan on the Management of Hypertension and Cardiovascular Risk

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

This survey is designed to investigate the effect of highland barley β-glucan supplementation on the regulatory of blood pressure, gut microbiota and cardiovascular risk fators in subjects with hypertention.

Detailed description

Highland barley β-glucan belongs to the group of prebiotics and has been found to be associated with multiple health benefits. However, its protective role in subjects with hypertension are remain unclear. This study aims to examine the effect of 12-week prebiotics supplementation on blood pressure management in subjects with hypertension. By understanding the mechanism by which prebiotics exert the beneficial effects, we can better control the rising prevalence of hypertension, which is a major risk factor for cardiovascular diseases.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTHighland barley β-glucan dietary supplement100 mL oral liquid mainly containing highland barley β-glucan once daily for 12 weeks
OTHERPlacebo controlsPlacebo with a similar appearance and taste to highland barley β-glucan supplement

Timeline

Start date
2022-10-17
Primary completion
2023-12-31
Completion
2030-12-31
First posted
2022-05-06
Last updated
2022-05-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05364736. Inclusion in this directory is not an endorsement.